Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Case #2: Therapeutic Strategies for Early Aggressive Disease (Slides With Audio)
Link ID 11674
Title Case #2: Therapeutic Strategies for Early Aggressive Disease (Slides With Audio)
Url http://www.medscape.com/viewarticle/585016?src=rss
Description Review the value of citrullinated peptide antibodies in predicting clinical outcomes for patients with undifferentiated or probable rheumatoid arthritis (RA).
Category Articles > Pharmacists
Keywords
Date Dec 18, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Pharmacists
1. Etanercept Has Benefits in Early Active Ankylosing Spondylitis
  The TNF inhibitor etanercept (Enbrel; Pfizer) may be more effective than sulfasalazine for early active ankylosing spondylitis (AS), results of a large randomized trial suggest. Reuters Health Information
Category:   Articles > Pharmacists


2. Adding Triamcinolone Does Not Improve Outcome of Migraine Therapy
  Adding triamcinolone to local anesthetics does not increase the efficacy of greater occipital nerve (GON) block and trigger-point injections for treatment of transformed migraine, researchers report in the April issue of the Journal of Neurology, Neurosurgery and Psychiatry. Reuters Health Information
Category:   Articles > Pharmacists


3. Prucalopride Effective for Severe Chronic Constipation
  Prucalopride (Resolor; Movetis) "significantly and consistently" improves bowel function in patients who are chronically constipated, Belgian researchers report in the March 9th issue of Gut. Reuters Health Information
Category:   Articles > Pharmacists


4. Post-Stroke Statins Improve Patient Outcomes
  Acute treatment with statins after ischemic stroke improves survival and functional outcome, new research shows. Reuters Health Information
Category:   Articles > Pharmacists


5. Abiraterone Acetate Promising for Refractory Prostate Cancer
  Abiraterone acetate plus prednisone has activity against castration-resistant prostate cancer and should be tested in phase III trials, researchers say in a February 16th online paper in the Journal of Clinical Oncology. Reuters Health Information
Category:   Articles > Pharmacists




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS